Search results for "HEMODIALYSIS"

showing 10 items of 125 documents

Calcium-enriched bread for treatment of uremic hyperphosphatemia

2004

Abstract Objective To assess phosphate-binding efficacy of a new food product, bread with unusually high calcium content (Ca-bread). Design and setting A randomized parallel group trial in the university hospital outpatient dialysis unit. Patients Fifty-three randomly selected uremic patients who met the following inclusion criteria: (1) required maintenance hemodialysis treatment, (2) were not to receive vitamin D throughout the study, (3) were nondiabetic, and (4) were diagnosed with hyperphosphatemia. Intervention Fifty-three patients were randomized into 2 groups: control group (n = 26), which received calcium acetate as a phosphate binder throughout the study, and Ca-bread group (n = 2…

Malemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentElemental calciumMedicine (miscellaneous)chemistry.chemical_elementAcetatesCalciumPhosphatesHyperphosphatemiachemistry.chemical_compoundAnimal scienceRenal DialysismedicineVitamin D and neurologyHumansUremiaNutrition and Dieteticsbusiness.industrydigestive oral and skin physiologyfood and beveragesBreadCalcium CompoundsMiddle Agedmedicine.diseasePhosphateDiet RecordsSurgeryPhosphate binderCalcium DietarychemistryNephrologyFood FortifiedCalcium CompoundsPatient CompliancePhosphorus DietaryCalciumFemaleHemodialysisbusinessJournal of Renal Nutrition
researchProduct

Changes in serum fetuin-A and inflammatory markers levels in end-stage renal disease (ESRD): effect of a single session haemodialysis.

2007

Background: The aim of the present study was to evaluate the effect of a single haemodialysis (HD) session on serum fetuin-A levels, considered a negative acute phase response marker; moreover, we evaluated the behaviour of fibrinogen and high sensitivity C-reactive protein (hsCRP) as acute phase response and chronic/subclinical inflammation markers, respectively, after a single HD session. Methods: Serum fetuin-A, albumin, hsCRP and fibrinogen were measured in 72 patients before and after a single HD session. Results: After a single HD session, we observed a significant increase in fibrinogen levels, while fetuin-A levels decreased (p<0.05). Also, hsCRP levels were significantly increased.…

Malemedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryInflammationFibrinogenEnd stage renal diseaseRenal DialysisInternal medicinemedicineHumansAgedbusiness.industryBiochemistry (medical)Acute-phase proteinAlbuminGeneral MedicineMiddle Agedmedicine.diseaseFetuinEndocrinologyKidney Failure ChronicFemaleHemodialysisalpha-Fetoproteinsmedicine.symptomInflammation MediatorsbusinessKidney diseasemedicine.drugClinical chemistry and laboratory medicine
researchProduct

Is It Possible to Create a “Mechanical” Arteriovenous Fistula in Hemodialysis Patients?

2010

Manual suturing still remains the best technique for the creation of vascular anastomoses on uremic patients with excellent results, despite being time consuming, difficult to perform with small vessels, and associated with a significant learning curve. We created a full mechanical arteriovenous fistula on a 65-year-old uremic patient with a new device already used in cardiac bypass surgery. The fistula was created automatically and rapidly, without the need for temporary occlusion of the artery, reducing the risk of blood clotting. We believe that mechanical devices may be useful to produce precise and fast anastomoses requiring minimal training for the surgeon.

Malemedicine.medical_specialtymedicine.medical_treatmentFistulaBiomedical EngineeringMedicine (miscellaneous)Arteriovenous fistulaBioengineeringAnastomosisBiomaterialsArteriovenous Shunt SurgicalRenal DialysisHumansMedicineDialysisAgedBrachiocephalic VeinsUremiaArteriovenous fistulaDialysisSutureless mechanical anastomosisUremiabusiness.industrySuture TechniquesEquipment DesignGeneral Medicinemedicine.diseaseUremiaSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureBypass surgeryRadial ArteryHemodialysisbusinessArteryArtificial Organs
researchProduct

Predicting patient outcome from acute renal failure comparing three general severity of illness scoring systems

2000

Predicting patient outcome from acute renal failure comparing three general severity of illness scoring systems.BackgroundA major problem of studies on acute renal failure (ARF) arises from a lack of prognostic tools able to express the medical complexity of the syndrome adequately and to predict patient outcome accurately. Our study was thus aimed at evaluating the predictive ability of three general prognostic models [version II of the Acute Physiology and Chronic Health Evaluation (APACHE II), version II of the Simplified Acute Physiology Score (SAPS II), and version II of the Mortality Probability Model at 24 hours (MPM24 II)] in a prospective, single-center cohort of patients with ARF …

Malemedicine.medical_specialtymedicine.medical_treatmentscoring systemsRisk AssessmentInterquartile rangePredictive Value of TestsInternal medicineSeverity of illnessOutcome Assessment Health CaremedicineHumansseverity of illness indexProspective StudiesSimplified Acute Physiology ScoreProspective cohort studymortality predictionAPACHEAgedAged 80 and overAPACHE IIbusiness.industryKidney Tubular Necrosis AcuteMiddle AgedSurgerycritical careacute tubular necrosisSAPS IINephrologyPredictive value of testsFemaleHemodialysisprognosisbusinessKidney International
researchProduct

Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects.

2008

&lt;i&gt;Aims:&lt;/i&gt; Our purpose was to evaluate, in a group of 42 end-stage renal disease patients who regularly undergo hemodialysis, some indexes of leukocyte activation, nitric oxide metabolites (NOx) and other parameters that reflect the oxidative stress before and after a standard hemodialysis session. &lt;i&gt;Methods:&lt;/i&gt; Elastase and myeloperoxidase (MPO) were determined by means of ELISA. The NO production was evaluated by a micromethod which measures the concentration of NOx. The oxidation of polyunsaturated fatty acids was evaluated in plasma by detection of thiobarbituric acid-reactive substances (TBARS). Total antioxidant status (TAS) was obtained using spectrophotom…

Malemedicine.medical_treatmentActivation markersOxidative phosphorylationHemodialysis Oxidative status Nitric oxide Elastase MyeloperoxidasePharmacologyNitric OxideThiobarbituric Acid Reactive SubstancesAntioxidantsNitric oxidechemistry.chemical_compoundRenal DialysisLeukocytesmedicineHumansAgedPeroxidasechemistry.chemical_classificationbiologyElastaseHematologyGeneral MedicineMiddle AgedOxidative StressEnzymechemistryNephrologyMyeloperoxidaseImmunologybiology.proteinKidney Failure ChronicFemaleHemodialysisLeukocyte Elastase
researchProduct

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (C…

2019

Background and aims Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with comorbidities. This study aimed to describe the effectiveness of OBV/PTV/r +/- DSV (3D/2D regimen) with or without ribavirin (RBV) in HCV or HCV/HIV co-infected patients with GT1/GT4 and CKD (IIIb-V stages), including those under hemodialysis and peritoneal dialysis in routine clinical practice in Spain in 2015. Material and methods Non-interventional, retrospective, multicenter data collection study in 31 Spanish sites. Socio-demographic, clinical variables, study treatment characteristics, effectiveness and toler…

Malemedicine.medical_treatmentHIV InfectionsHepacivirus0302 clinical medicine:Infections::Virus Diseases::Hepatitis Viral Human::Hepatitis C::Hepatitis C Chronic [DISEASES]ribavirina2-Naphthylaminemediana edad:virosis::infecciones por virus ARN::infecciones por Retroviridae::infecciones por Lentivirus::infecciones por VIH [ENFERMEDADES]ancianoSulfonamidesCoinfectionfarmacoterapiaLiver Diseasesvirus diseasesValineInfeccions per VIH - TractamentCirrhosisNephrology/drug therapyMedicine030211 gastroenterology & hepatologyDrug Therapy Combinationinsuficiencia renalmedicine.medical_specialty:virosis::hepatitis viral humana::hepatitis C::hepatitis C crónica [ENFERMEDADES]GenotypeProlineSciencecompuestos macrocíclicosSurgical and Invasive Medical ProceduresGastroenterology and HepatologyAntiviral AgentsMicrobiologyUrinary System ProceduresPeritoneal dialysis03 medical and health sciencesDrug TherapyHumansLost to follow-upRenal Insufficiency ChronicUracilAgedRetrospective StudiesFlavivirusesanilidasOrganismsOrgan Transplantationmedicine.diseasedigestive system diseasesRegimenchemistryHIV-1Malalties del ronyóCarbamatesgenotipoCyclopropanesRNA virusesantivíricosSustained Virologic ResponsePhysiologyhumanoschemistry.chemical_compoundChronic Kidney DiseaseMedicine and Health SciencesRenal TransplantationAnilidesRenal Insufficiency030212 general & internal medicinePathology and laboratory medicinecoinfecciónMultidisciplinaryKidney diseasesHepatitis C virus:Infections::Infections::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::Infections::Virus Diseases::HIV Infections [DISEASES]resultado del tratamientoQR:Infections::Coinfection [DISEASES]Middle AgedMedical microbiologyHepatitis CTreatment OutcomeInfectious DiseasesTolerabilityResearch DesigncarbamatosVirusesFemaleHemodialysisPathogensVIH-1Research ArticleGlomerular Filtration RateMacrocyclic CompoundsClinical Research DesignLactams MacrocyclicResearch and Analysis MethodssulfonamidasRenal DialysisInternal medicineRibavirinMedical DialysismedicineDialysisTransplantationRenal Physiology/tratamiento farmacológicoRitonavirBiology and life sciencesbusiness.industryRibavirinestudios retrospectivosViral pathogensHepatitis C ChronicHepatitis virusesMicrobial pathogens:enfermedades parasitarias::coinfección [ENFERMEDADES]Spaindiálisis renalCo-InfectionsPhysical therapyinfecciones por VIHAdverse EventsbusinessHepatitis C - TractamenturaciloKidney diseasePLoS ONE
researchProduct

Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit.

2005

ABSTRACT We analyzed a hepatitis C virus (HCV) transmission case in the hemodialysis unit of a private clinic by sequencing two genome regions of virus isolates from a number of patients attending this unit and some external controls. The analysis of 337 nucleotides (nt) in the NS5B region did not provide enough resolution to ascertain which patients were actually involved in the outbreak and the potential source. Nevertheless, this region allowed the exclusion of several patients as putative sources of the transmission case based on their genotypes and phylogenetic relationships. On the other hand, the analysis of several 472-nt-long clone sequences per sample in a more rapidly evolving re…

Microbiology (medical)MaleEpidemiologyHepatitis C virusMolecular Sequence DataHepacivirusBiologyViral Nonstructural Proteinsmedicine.disease_causeVirusDisease Outbreakschemistry.chemical_compoundFlaviviridaeViral Envelope ProteinsmedicineHumansGenetic variabilityNS5BCross InfectionMolecular EpidemiologyMolecular epidemiologyOutbreakSequence Analysis DNAbiology.organism_classificationVirologyHepatitis CHypervariable regionHemodialysis Units HospitalchemistryFemaleJournal of clinical microbiology
researchProduct

COVID-19—Importance for Patients on the Waiting List and after Kidney Transplantation—A Single Center Evaluation in 2020–2021

2021

(1) Background: Dialysis patients and recipients of a kidney allograft are at high risk for infection with SARS-CoV-2. It has been shown that the development of potent neutralizing humoral immunity against SARS CoV-2 leads to an increased probability of survival. However, the question of whether immunocompromised patients develop antibodies has not yet been sufficiently investigated; (2) Methods: SARS-CoV-2 antibodies were examined in hemodialysis patients on the waiting list for kidney transplantation as well as patients after kidney transplantation. Patients were interviewed about symptoms and comorbidities, BMI, and smoking history; (3) Results: SARS-CoV-2 antibodies were found in 16 out…

Microbiology (medical)medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.medical_treatmentkidney transplantationlcsh:MedicineCOVID-19; waiting list; hemodialysis; kidney transplantationSingle CenterArticleInternal medicinemedicineImmunology and AllergyMolecular BiologyKidney transplantationKidneyhemodialysisGeneral Immunology and Microbiologybiologybusiness.industrylcsh:RCOVID-19waiting listmedicine.diseaseVaccinationInfectious Diseasesmedicine.anatomical_structureHumoral immunitybiology.proteinHemodialysisAntibodybusinessPathogens
researchProduct

Prevalence of biliary lithiasis in a Sicilian population of chronic renal failure patients.

2003

BACKGROUND The aim of this study was to evaluate the prevalence of biliary lithiasis (BL) and associated risk factors in a population of undialysed patients with chronic renal failure (CRF), and to compare these with findings we had obtained previously in chronic haemodialysis (HD) patients and in subjects from the general population located in the same geographic region. METHODS A total of 118 CRF patients on conservative treatment were included in the study. In all subjects, we measured several clinical and humoral parameters potentially correlated with BL. Liver and biliary tract ultrasonography was performed with a 3.5 MHz linear probe after at least 12 h of fasting. RESULTS The prevale…

NephrologyMalemedicine.medical_specialtyEpidemiologymedicine.medical_treatmentPopulationGastroenterologySeverity of Illness IndexCholelithiasisRenal DialysisRisk FactorsInternal medicineSeverity of illnessmedicineChronic renal failurePrevalenceHumansRisk factoreducationBiliary TractSicilyAgedUltrasonographyeducation.field_of_studyTransplantationbusiness.industryMiddle Agedmedicine.diseaseSurgeryTransplantationBiliary lithiasiNephrologyKidney Failure ChronicFemaleHemodialysisRisk factorbusinessBody mass indexKidney diseaseNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

A reinforcement learning approach for individualizing erythropoietin dosages in hemodialysis patients

2009

This paper presents a reinforcement learning (RL) approach for anemia management in patients undergoing chronic renal failure. Erythropoietin (EPO) is the treatment of choice for this kind of anemia but it is an expensive drug and with some dangerous side-effects that should be considered especially for patients who do not respond to the treatment. Therefore, an individualized treatment appears to be necessary. RL is a suitable approach to tackle this problem. Moreover, resulting policies are similar to medical protocols, and hence, they can easily be transferred to daily practice. A cohort of 64 patients are included in the study. An implementation of the Q-learning algorithm based on a st…

Nephrologymedicine.medical_specialtyDosebusiness.industryAnemiamedicine.medical_treatmentGeneral Engineeringmedicine.diseaseComputer Science ApplicationsArtificial IntelligenceErythropoietinInternal medicineHealth careCohortmedicineReinforcement learningHemodialysisbusinessIntensive care medicinemedicine.drugExpert Systems with Applications
researchProduct